Flexible CMO Luina Bio is an established biopharmaceutical contract manufacturer in Australia with over 20 years of experience and capabilities spanning process development to GMP manufacturing for recombinant proteins, vaccines, and live bio-therapeutics, presenting a strong outsourcing partner for pre-clinical to Phase 3 programs.

Global Collaboration The company has a track record of supporting Australian, European, American, and Asian clients, and has formed partnerships and MoUs with universities and industry players, signaling readiness for international collaborations and technology transfers.

Expansion Momentum Recent activity highlights include launching multiple process development labs and introducing the Luina Flexible Manufacturing Platform to accelerate microbiome and recombinant protein projects, indicating capacity to scale projects and shorten development timelines.

Strategic Partnerships Past and ongoing partnerships with Technovalia, Xingtech, Griffith University, and Dyadic demonstrate a strong network for technology transfer, diagnostic/gene expression platforms, and vaccine development, which can be leveraged for co-development or licensing opportunities.

Limited Revenue Footprint With revenue listed as under one million dollars and a mid-sized team, there is an opportunity to position Luina Bio for higher-value, higher-margin CRO/CMO engagements, particularly for early-stage programs seeking GMP batches and pre-clinical material.